Founded in 2017, Concerto HealthAI specializes in designing and delivering oncology research and data analytics. Their platform analyzes large datasets of clinical and genomic data to identify patterns and insights for personalized cancer treatment. They also conduct oncology health outcomes and clinical trial efficiency research, using custom patient surveys to evaluate existing treatments and develop new ones. Concerto HealthAI's integrated real-world data and AI-driven solutions aim to transform how insights are generated and accelerate therapeutic innovations for patients.